by Jason Heaviland | Aug 25, 2026
Discovery Exposomics profiling of 30 serum samples identified 240 exposure chemicals, with 138 showing significant differences between Alzheimer’s disease and healthy control groups. The analysis revealed distinct exposure patterns and enrichment across chemical...
by Jason Heaviland | Aug 25, 2026
Targeted Exposomics profiling of 30 serum samples revealed distinct chemical exposure patterns associated with Alzheimer’s disease. Twenty-nine chemical exposures were detected, with several showing significant differences between Alzheimer’s disease and control...
by Jason Heaviland | Aug 20, 2026
Exposomics Reveals Differential Exposures And Chemical Subgroups ow can researchers identify which environmental chemicals differ between patient groups? How do they distinguish environmental exposures from naturally occurring metabolites? And how can machine learning...
by Jason Heaviland | Aug 4, 2026
Characterizing Chemical Exposures During Pregnancy Through Targeted and Discovery Exposomics™ Exposomics provides a comprehensive approach to characterize exogenous chemical exposures during pregnancy by profiling compounds in maternal and placental samples. In this...
by Jason Heaviland | Jul 23, 2026
How Genomics and Exposomics Will Transform Precision Medicine Genomics has transformed precision medicine by revealing an individual’s genetic blueprint—but genetics alone cannot explain why people with similar genomes often experience very different health...
